country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-146277

Copy Link Print Information

CBP/p300-IN-19

CBP/p300-IN-19 is a potent p300/CBP HAT inhibitor with IC₅₀s of 1.4, 2.2, >100, >100 µM for p300-HAT, CBP-HAT, PCAF, Myst3, respectively. CBP/p300-IN-19 shows antitumor activity.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 2592638-13-4
화학식: C₃₀H₂₇N₃O₃
분자량:477.55

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (272 KB)

CBP/p300-IN-19 Chemical Structure

CAS No.: 2592638-13-4

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

CBP/p300-IN-19 is a potent p300/CBP HAT inhibitor with IC₅₀s of 1.4, 2.2, >100, >100 µM for p300-HAT, CBP-HAT, PCAF, Myst3, respectively. CBP/p300-IN-19 shows antitumor activity^[1].

IC₅₀ & Target

^[1]

Myst3

>100 μM (IC₅₀)

p300-HAT

1.4 μM (IC₅₀)

CBP-HAT

2.2 μM (IC₅₀)

PCAF

>100 μM (IC₅₀)

All Histone Acetyltransferase Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
LNCaP	EC₅₀	6.2 μM Compound: 29	Antiproliferative activity against human LNCaP cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human LNCaP cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
MCF7	EC₅₀	5.3 μM Compound: 29	Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
MDA-MB-231	EC₅₀	8.5 μM Compound: 29	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
MOLM-13	EC₅₀	3.6 μM Compound: 29	Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
MV4-11	EC₅₀	8.7 μM Compound: 29	Antiproliferative activity against human MV4-11 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human MV4-11 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
PANC-1	EC₅₀	1.2 μM Compound: 29	Antiproliferative activity against human PANC-1 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human PANC-1 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
PC-3	EC₅₀	4.4 μM Compound: 29	Antiproliferative activity against human PC-3 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human PC-3 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]
RPMI-8226	EC₅₀	6.4 μM Compound: 29	Antiproliferative activity against human RPMI-8226 cells assessed as reduction in cell growth incubated for 5 days by XTT assay Antiproliferative activity against human RPMI-8226 cells assessed as reduction in cell growth incubated for 5 days by XTT assay	[PMID: 35512565]

In Vitro

CBP/p300-IN-19 (compound 29) shows antiproliferative activity with EC₅₀s of 5.3, 8.5, 6.2, 4.4, 1.2, 4.3, 3.6, 8.7, 6.4 µM for MCF-7, MDA-MB231, LNCaP, PC-3, PANC-1, MDA-PANC-28, Molm-13, MV4;11, RPMI-8226 cells, respectively^[1].
CBP/p300-IN-19 (0, 5, 10 µM; 12 h) dose-dependenly inhibits the acetylation of H3K18, H3K9 and K27^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

Kasumi-1 leukemia cells
Concentration:

0, 5, 10 µM
Incubation Time:

12 h
Result:

Dose-dependently inhibited the acetylation of H3K18, H3K9 and K27.

Related Protocols :

Subcutaneous Cell-Line-Derived Xenograft

Chemical Information

CAS No. 2592638-13-4
분자량 477.55
화학식 C₃₀H₂₇N₃O₃
SMILES

C1(C2=CC=C(C3=COC=C3)C=C2)=NC=C(OCC4CCNCC4)N=C1C5=CC=C(C6=COC=C6)C=C5
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (272 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Nie S, et al. Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP. Eur J Med Chem. 2022 Jul 5;237:114407. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기